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Introduction: A steady rise in incidence of oral cavity and oropharyngeal cases 
especially among young males with no history of tobacco smoking or alcohol consumption have 
given rise to a new risk factor, namely human papillomavirus (HPV). The role of HPV in these 
cancers are evidenced in many studies. Local studies on this trend are scarce and HPV 
prevalence among local population has not been undertaken before.  
 
Objectives: This study was conducted to determine prevalence and association of HPV 
among oral cavity/oropharyngeal cancer patients and healthy local population. It also aims to 
identify the association of HPV and risk factors such as smoking, alcohol consumption, betel nut 
chewing and family history of cancer.  
 
Methodology:  This is a case-control study involving a test group (oral cavity and 
oropharyngeal cancer patients) and a control group (healthy individuals). HPV status is tested 
via salivary rinse samples collected using Diacarta Quantivirus
®
 HPV salivary rinse collection 
kit and processed using Diacarta Quantivirus
®
 HPV E6/E7 RNA assay. Data collection and 
salivary sample collection were done with informed consent from July 2013 till June 2014 
involving patients from 3 different institutions to achieve optimal sample size.  
 
Results: This study involves 58 subjects, consisting of 29 test subjects who are patients 
with oral cavity cancer and 29 control subjects who are healthy. There were no patients with 
oropharyngeal cancer in the test group. HPV prevalence was found to be 55.1% among test 
subjects and 3.4% among control subjects. This was found to be significant (p=0.001) with odds 
ratio of 33.90 (95% CI 3.88, 295.99). Among the risk factors, smoking habit was seen in 51.2% 
of test subjects and 13.8% of control subjects. This association was found to be significant 
(p=0.041) with odds ratio of 4.36 (95% CI 1.06, 17.86). Multicolinearity and interaction term 
were checked and none found. Alcohol consumption was found to be insignificant (p=0.241) in 
this study. Family history of cancer was seen in 31.0% of subjects in test group and 6.9% in 
control group. This was found to be significant (p=0.019) with an odds ratio of 6.08 (95% CI 
1.181, 31.244).  
 
Conclusion: HPV prevalence among oral cavity patients was found to be high and this 
pivotal result demonstrates HPV infection is now an established risk factor in this country. 
Smoking habit was also found to be a significant risk factor among these patients and did not 
interact or confound the factor of HPV infection.  
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ABSTRAK 
 
Pengenalan: Kenaikan bilangan kes kanser rongga mulut dan kerongkong yang berterusan 
terutama di kalangan lelaki muda yang tidak mempunyai sejarah merokok atau penggunaan 
alkohol telah membawa kepada penemuan faktor risiko baru, iaitu Human Papillomavirus 
(HPV). Peranan HPV dalam kanser ini dibuktikan dalam beberapa kajian. Kajian tempatan 
berkenaan perkara ini adalah terhad dan kelaziman HPV di kalangan penduduk tempatan belum 
dikenalpasti sehingga kini. 
Objektif: Kajian ini dijalankan untuk menentukan kelaziman dan kaitan HPV antara pesakit 
kanser rongga mulut / kerongkong dan penduduk tempatan sihat. Ia juga bertujuan untuk 
mengenal pasti kaitan HPV dengan faktor-faktor risiko seperti merokok, pengambilan alkohol, 
tabiat mengunyah pinang dan sejarah kanser keluarga. 
Metodologi: Kajian ini merupakan jenis kes-kawalan yang melibatkan kumpulan ujian (pesakit 
kanser rongga mulut dan kerongkong) dan kumpulan kawalan (individu yang sihat). Status HPV 
diuji melalui sampel bilasan mulut yang dikumpul menggunakan kit penggumpulan bilasan 
mulut Diacarta Quantivirus ® HPV dan diproses menggunakan Diacarta Quantivirus ® HPV E6 / 
E7 RNA assay. Pengumpulan data dan sampel bilasan mulut telah dilakukan dengan persetujuan 
pesakit mulai dari Julai 2013 hingga Jun 2014 dan melibatkan pesakit dari 3 institusi yang 
berbeza untuk menepati saiz sampel kajian yang optimum.  
Keputusan: Kajian ini melibatkan 58 peserta, yang terdiri daripada 29 pesakit kumpulan ujian 
yang terdiri daripada pesakit kanser rongga mulut dan 29 peserta kawalan yang sihat. Tiada 
pesakit dengan kanser kerongkong dalam kumpulan ujian. HPV didapati positif sebanyak 55.1% 
di kalangan pesakit kumpulan ujian dan 3.4% di kalangan peserta kawalan. Keputusan ini 
xiv 
 
didapati signifikan (p = 0.001) dengan nisbah kemungkinan (odds ratio) sebanyak 33.90 (95% 
CI 3.88, 295,99). Antara faktor-faktor risiko, tabiat merokok dilihat dalam 51.2% daripada 
pesakit kumpulan ujian dan 13.8% daripada peserta kawalan. Keputusan  ini telah didapati 
signifikan (p = 0.041) dengan nisbah kemungkinan (odds ratio) 4.36 (95% CI 1.06, 
17.86). Interaksi antara faktor tabiat merokok dan HPV diperiksa dan tidak 
dijumpai. Pengambilan alkohol didapati tidak signifikan (p = 0.241) dalam kajian ini. Sejarah 
kanser dalam keluarga dilihat dalam 31.0% daripada pesakit dalam kumpulan ujian dan 6.9% 
dalam kumpulan kawalan. Keputusan ini didapati signifikan (p = 0.019) dengan nisbah 
kemungkinan (odds ratio) 6.08 (95% CI 1,181, 31,244). 
 
Kesimpulan: Kelaziman HPV di kalangan pesakit rongga mulut telah didapati tinggi dan ini 
menunjukkan jangkitan HPV kini merupakan faktor risiko yang penting di negara ini. Tabiat 
merokok juga didapati menjadi faktor risiko yang ketara di kalangan pesakit-pesakit ini dan 
tidak berinteraksi dengan faktor jangkitan HPV.  
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ABSTRACT 
 
Introduction: A steady rise in incidence of oral cavity and oropharyngeal cases especially 
among young males with no history of tobacco smoking or alcohol consumption have given rise 
to a new risk factor, namely human papillomavirus (HPV). The role of HPV in these cancers are 
evidenced in many studies. Local studies on this trend are scarce and HPV prevalence among 
local population has not been undertaken before.  
Objective: This study was conducted to determine prevalence and association of HPV among 
oral cavity/oropharyngeal cancer patients and healthy local population. Secondary objective was 
to identify the association of HPV and risk factors such as smoking, alcohol consumption, betel 
nut chewing and family history of cancer.  
Methodology:  This was a case-control study involving a test group (oral cavity and 
oropharyngeal cancer patients) and a control group (healthy individuals). HPV status was tested 
via salivary rinse samples collected using Diacarta Quantivirus® HPV salivary rinse collection 
kit and processed using Diacarta Quantivirus®
Result: This study involved 58 subjects, consisting of 29 test subjects who were patients with 
oral cavity cancer and 29 control subjects who were healthy. There were no patients with 
oropharyngeal cancer in the test group. HPV prevalence was found to be 55.1% among test 
subjects and 3.4% among control subjects. This was found to be significant (p=0.001) with odds 
ratio of 33.90 (95% CI 3.88, 295.99). Among the risk factors, smoking habit was seen in 51.2% 
of test subjects and 13.8% of control subjects. This association was found to be significant 
(p=0.041) with odds ratio of 4.36 (95% CI 1.06, 17.86). Multicolinearity and interaction term 
 HPV E6/E7 RNA assay. Data collection and 
salivary sample collection were done with informed consent from July 2013 till June 2014 
involving patients from 3 different institutions to achieve optimal sample size.  
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were checked and none found. Alcohol consumption was found to be insignificant (p=0.241) in 
this study. Family history of cancer was seen in 31.0% of subjects in test group and 6.9% in 
control group. This was found to be significant (p=0.019) with an odds ratio of 6.08 (95% CI 
1.181, 31.244).  
Conclusion: HPV prevalence among oral cavity patients was found to be high and this pivotal 
result demonstrates HPV infection is now an established risk factor in this country. Smoking 
habit was also found to be a significant risk factor among these patients and did not interact or 
confound the factor of HPV infection.  
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1.   INTRODUCTION 
 
1.1   ORAL CAVITY ANATOMY 
Oral cavity, or better known as the mouth, is an important structure on the face and is 
one of the first structures noted when looking at a face of an individual (Lewis, 
1918). Its primary function is to serve as the entrance of the alimentary tract that 
initiates the digestive process by salivation, bolus formation and propulsion of the 
bolus into the pharynx. It also functions as a secondary respiratory conduit after the 
nose, a site of sound modification & pronunciation for speech and chemosensory 
organ. Lips, in particular, play a role in speech production, whistling, singing, 
playing of certain musical instruments and human behavioural communication such 
as smiling & kissing.  
 
Oral cavity is oval shaped and it extends from the lips and cheeks externally to the 
anterior pillars of the fauces (palatoglossal arches) internally as seen in Figure 1.1. 
Hard palate forms the roof of the oral cavity and separates it from the nasal cavity. 
Floor of the mouth is formed by the mylohyoid muscles and is occupied by the 
tongue. Lateral wall are defined by the cheeks and retromolar regions.  
 
It is divided into oral vestibule and oral cavity proper. Oral vestibule is the anterior 
most portion of the oral cavity and consists of a slit-like space between the lips or 
cheeks on one side and the teeth on the other. It is limited, both superiorly and 
inferiorly, by the reflection of the mucous membrane from the lips and cheeks to the 
gum covering the upper and lower jaw alveolar arch respectively. When the teeth 
occlude, the oral vestibule becomes a closed space that only communicates with the 
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oral cavity proper in the retromolar regions behind the last molar tooth on each side. 
Oral cavity is bounded laterally and anteriorly by the alveolar arches & teeth and 
communicates posteriorly to the oropharynx via the oropharyngeal isthmus. It is 
roofed by the hard and soft palates, while the greater part of the floor is formed by 
the tongue with the remainder by the reflection of the mucous membrane from the 
sides. Mucosa of the oral cavity is generally made up of non-keratinized stratified 
squamous epithelium except anterior 2/3 of the dorsal surface of the tongue which 
consists of keratinized stratified squamous epithelium. Three pairs of major salivary 
glands (parotid, submandibular and sublingual) open into the mouth together with 
numerous minor salivary glands (labial, buccal, palatal, lingual).  
 
 
Figure 1.1: Anatomy of the oral cavity (Source: card 234.gif, Applied Biology – 
Study cards, http://www.mhhe.com/biosci/abio/images/card234.gif) 
 
The gums (or gingiva) are composed of dense fibrous tissues which is closely 
attached to the periosteum of the alveolar processes and surrounding the necks of the 
teeth. They are covered by the mucous membrane which is smooth and vascular.  
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The palate is divisible into 2 regions, hard palate anteriorly and soft palate 
posteriorly. The hard palate is formed by the palatine processes of the maxilla and 
horizontal plates of the palatine bones. Oral mucosa is tightly bound to the 
underlying periosteum while in posterior and lateral regions it possesses a submucosa 
where neurovascular bundles lie. The periphery of the hard palate is covered by 
gingiva and a zone running anteroposteriorly in the midline as a narrow, low ridge is 
the palatine raphe. This zone ends anteriorly in a small papilla corresponding with 
the incisive canal. This surface is covered with stratified squamous epithelium and 
numerous palatal mucous salivary glands between the mucous membrane and the 
bone surface especially in the posterior half.  
 
The soft palate is a mobile flap suspended from the posterior border of the hard 
palate which forms an incomplete septum between mouth and pharynx. It consists of 
a fold of mucous membrane enclosing muscular fibers, an aponeurosis, vessels, 
nerves, adenoid tissue, mucous glands and some taste buds on its oral surface. When 
occupying its usual relaxed position, its anterior surface is concave, continuous with 
the roof of the mouth, and marked by a median raphé. Its posterior surface is convex, 
and continuous with the mucous membrane covering the floor of the nasal cavities. 
Its upper border is attached to the posterior margin of the hard palate, and its sides 
are blended with the pharynx. Its lower border is free and its lower portion, which 
hangs like a curtain between the mouth and pharynx is termed the palatine velum. 
Hanging from the middle of its lower border is a small, conical, pendulous process, 
the palatine uvula; and arching lateralward and downward from the base of the uvula 
on either side are two curved folds of mucous membrane, containing muscular fibers, 
called the arches or pillars of the fauces.  
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The floor of mouth comprises a small horseshoe shaped region beneath the tongue as 
seen in the Figure 1.1. A fold of tissue called the lingual frenulum is seen to extend 
onto the inferior surface of the tongue in the midline. Sublingual papilla is also 
located at the base of tongue and the submandibular salivary ducts open into this 
papilla. Sublingual folds are noted at either side of sublingual papilla and the muscle 
forming the floor of mouth is the mylohyoid muscle.  
 
Tongue is situated in the floor of the mouth within the curve of the mandibular body. 
It functions as the organ of the sense of taste and plays an important role in speech. It 
also assists in mastication and deglutition of food. Its root is directed backward, and 
connected with the hyoid bone by the hyoglossus and genioglossus muscles and the 
hypoglossal membrane; with the soft palate by the glossopalatine arches; and with 
the pharynx by the superior pharyngeal constrictor and the mucous membrane. The 
apex is thin, narrow and directed forward against the lingual surfaces of the lower 
incisor teeth. It is a muscular structure invested by mucous membrane, submucous 
fibrous layer and is provided with both mucous and serous glands. Dorsum of the 
tongue is convex and marked by median sulcus which divides it in symmetrical 
halves. This sulcus ends 2.5cm from the root of the tongue in a depression called 
foramen cecum. A shallow grove called sulcus terminalis runs lateralward and 
anteriorly on either side to the margin of tongue.  
 
The anterior two-thirds of dorsum of tongue is anterior to this sulcus and its surface 
is rough and covered with papilla. The posterior third is smoother and contains 
mucous glands and lymph follicles (lingual tonsil). There are 3 types of papillae, that 
are filiform, fungiform and circumvallate papillae. All papillae except filiform 
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papillae bear taste buds. The tongue is divided into lateral halves by a median fibrous 
septa which extends throughout its entire length and it’s fixed below to the hyoid 
bone. Its movement is controlled by 2 sets of muscles on either half of the tongue, 
which are the extrinsic and intrinsic muscles. The extrinsic muscles consist of 
genioglossus, chondroglossus, hyoglossus and styloglossus. It originates from 
structures outside the tongue and insert into the tongue. It plays a role in the overall 
position of the tongue which includes protrusion, retraction, depression and elevation 
of the tongue. The intrinsic muscles consist of superior longitudinal muscle, inferior 
longitudinal muscle, verticalis muscle and transverses muscle. These four paired 
muscles originate and insert within the tongue, running along its length. It alters the 
shape of tongue by lengthening and shortening it, curling and uncurling its apex and 
edges, & flattening and rounding its surface.  
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1.2   ORAL CAVITY CANCERS 
Oral cavity cancers accounts to 2.64% of all cases worldwide in the year 2000 
according to Parkin (2001). Incidence of oral cavity cancer worldwide in the year 
2000 was 267,000 cases while prevalence of this cancer was 707,000 cases.  
 
There is a wide geographical variation in the incidence of oral cancers. 
Warnakulasuriya (2009) outlined the areas characterized by high incidence rates are 
found in South and Southeast Asia (eg Sri Lanka, India, Pakistan and Taiwan), parts 
of Western (eg. France) and Eastern Europe (eg. Hungary, Slovakia, Slovenia), parts 
of Latin America and the Caribbean (eg. Brazil, Uruguay, Puerto Rico) and in Pacific 
regions (eg. Papua New Guinea). 
 
Local epidemiology data also reveals high number of oral cancers in Malaysia. 
According to National Cancer Registry Report in 2007 (Omar and Ibrahim, 2008), 
there were a total of 353 cases of oral cancer cases consisting of lip, tongue and 
mouth cancers, in which 171 cases were male and 182 cases were female. It was to 
be the 21st most common cancer in general population, 17th most common in males 
and 16th
  
 most common in females. Further analysis revealed it was predominant 
among the Indian ethnic group as tongue and mouth cancers were among 10 most 
common cancers in both male and female. Table 1.1 and Table 1.2 show gender-
specific distribution of oral cancer incidence by ethnic group and site of cancer in 
2007 followed by Figure 1.2 illustrating age-specific distribution of oral cancers by 
gender in 2007. 
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Table 1.1: Gender-specific distribution of oral cancer incidence by ethnic group in 
2007  
 
Ethnic group Gender 
Male Female 
Malay  52 57 
Chinese 62 32 
Indian 36 70 
 
Table 1.2: Gender-specific distribution of oral cancer incidence by site of cancer in 
2007  
 
Site of cancer Gender 
Male Female 
Lip  9 8 
Tongue  93 78 
Mouth 69 96 
 
 
Figure 1.2: Age-specific oral cancer incidence by gender in 2007  
 
Although there were 353 cases, only 205 cases had recorded the disease stage in 
which 12.1% presented in stage I, 23.3% in stage II, 20.0% in stage III and 44.6% in 
stage IV. 
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In general, oral cavity cancers are mostly squamous cell carcinoma and have certain 
related risk factors. Table 1.3 illustrates its histopathology subtypes and associated 
risk factors.  
 
Table 1.3: Histopathological subtypes and associated risk factors of oral cancers 
(Webster, 2008; Bradley, 2008; Birchall and Pope, 2008) 
 
Site Histopathology 
Subtype 
Risk factors 
Oral Cavity Cancer 
-Tongue 
-Mouth 
-Hard Palate 
-Buccal 
-Floor of mouth 
-Squamous cell (90%) 
-Tumours arising   
  from minor salivary   
  glands (5%) 
-Melanoma, Lymphoma,     
  Sarcoma (1-2%) 
-Tobacco smoking 
-Excessive consumption of alcohol    
-HPV infection 
-Diet & nutrition deficiencies (namely    
 vitamin A, C, E, iron, selenium, folate) 
-Pre-malignant conditions  
 (leukoplakia, erythroplakia) 
-Betel quid chewing 
-Poor oral hygiene 
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1.3   OROPHARYNGEAL ANATOMY 
Oropharynx is one of 3 segments of the pharynx which forms a conduit for 
respiration, food passage and speech as shown in Figure 1.3 & Figure 1.4 (Lewis, 
1918). Pharynx is a fibromuscular tube attached to base of skull and continuous 
below with the esophagus. It is 12cm in length. Superiorly, it is attached to the base 
of skull till the lower border of cricoid cartilage inferiorly at level C6 vertebra. 
Posterior to it is the prevertebral fascia while the anterior wall is largely deficient as 
it communicates with nose and mouth. 
 
 
Figure 1.3: Anatomy of pharynx and its segments (Source: Figure 1, Head and Neck 
Tumours, http:/www.surgery.gr/index.php/news/408-head-and-neck-tumors) 
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Figure 1.4: Sagittal section of the nose, mouth and larynx (Source: Figure 994, 
Chapter XI- Splanchnology, Gray’s Anatomy of the Human Body 20th
 
 Edition.  
https://s.yimg.com/lq/i/edu/ref/ga/l/994.gif) 
The oropharynx segment extends from lower surface of soft palate to upper border of 
epiglottis (halfway down C3 vertebral body). It opens anteriorly into the mouth via 
isthmus of the fauces while its lateral wall is the palatine tonsil between the two 
palatine arches. Structures within it include palatine tonsil & its surrounding arches, 
lingual tonsil and valleculla as illustrated in Figure 1.5.  
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Figure 1.5: Illustration of the oral cavity and oropharynx (Source:- mouth,jpg, SEER 
training modules, National Cancer Institute. http://training.seer.cancer.gov/images/ 
head-neck/mouth.jpg) 
 
There are 2 pairs of arches on both sides of the lateral wall of the oropharynx, which 
are palatopharyngeal and palatoglossal arches. These are projecting ridges occurring 
bilaterally at the sides of the posterior part of tongue forming the pillars of the 
fauces. The palatoglossal arch, also called the anterior pillar of fauces, runs 
downward, lateralward and forward to the side of base of tongue from the soft palate 
and is formed by the projection of the palatoglossus muscle covered by mucous 
membrane. The palatopharygeal arch, also called the posterior pillar of fauces, is 
larger and projects downward, lateralward and backward to the side of the pharynx. 
It is formed by the projection of palatopharyngeus muscle covered by mucous 
membrane. These 2 arches are separated by a triangular interval on either side called 
tonsillar fossa in which the palatine tonsil is situated.  
 
Palatine tonsil is a large collection of lymphoid tissue which projects into oropharynx 
from tonsillar fossa. It extends up to soft palate superiorly and down to dorsum of the 
tongue and can be divided to upper pole, body & lower pole. Palatoglossal fold is 
found anterior to tonsil while the palatopharyngeal fold is found posterior to it as 
shown in Figure1.6. The medial surface is covered by pharyngeal mucosa with 
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epithelial downgrowths (tonsilar crypts) on its surface. Its floor (lateral wall) consists 
of lower part of the superior constrictor muscle and is covered by fibrous tissue with 
forms the tonsillar hemicapsule. 
 
 
Figure 1.6: A, Right palatine tonsil and its surroundings, medial aspect. 
B, Horizontal section throught the tonsil (Source: Figure 53-6, Basic Human 
Anatomy, Dartmouth Medical School. http://www.dartmouth.edu/~humananatomy/ 
figures/chapter_53/53-6_files/image002.jpg) 
 
Palatine tonsil is supplied mainly by tonsillar branch of facial artery with 
contributions from lingual, ascending pharyngeal, and ascending & greater palatine 
vessels. Its lymphatics drain to deep cervical nodes especially jugulodigastric nodes 
below angle of mandible. The mucous membrane overlying the tonsil is supplied by 
tonsillar branch of glossopharyngeal nerve.  
 
Lingual tonsil is a rounded mass of dense and nodular lymphatic tissue on dorsal 
surface of base of tongue. Its surface consists of stratified squamous epithelium 
which invaginates as a single crypt into each lingual tonsil. Valleculla is the area 
between epiglottis and posterior surface of tongue and consists of shallow fossa 
separated by median glossoepiglottic fold as shown in Figure 1.7. It is limited 
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inferolaterally by lateral glossoepiglottic folds and sensory innervation is by internal 
laryngeal nerve.  
 
 
Figure 1.7: Anterior wall of laryngopharynx (Source: Anatomy of pharynx, 
Encyclopedia of Science. http://www.daviddarling.info/images/laryngopharynx.jpg) 
 
The wall of the oropharynx is made up of 4 layers, which are mucous membrane 
lining, pharyngobasilar fascia, muscle layers and buccopharyngeal fascia. The 
mucous membrane is lined by non-keratinizing stratified squamous epithelium 
followed by connective tissue lamina propria immediately beneath the epithelium. 
The pharyngobasilar fascia is a fibrous layer attached superiorly to the basilar region 
of occipital bone and petrous part of temporal bone medial to carotid canal. It bridges 
below Eustachian tube and extends forward to posterior border of medial pterygoid 
plate and pterygomandibular raphe. It also bridges the gap between superior 
constrictor and base of skull. It is strengthened posteriorly by a fibrous band attached 
above to pharyngeal tubercle and passes down as median raphe which serves as an 
attachment to the constrictor muscles. The muscular layer is further divided to inner 
longitudinal and outer circular layers. The inner longitudinal layer is formed by 3 
paired muscles, that are stylopharyngeus, palatopharyngeus and salpingopharyngeus. 
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The outer circular layer also consists of 3 paired muscles, which are superior, middle 
and inferior constrictors. Each constrictor muscle is shaped like a fan which arise 
from lateral wall and sweep around to be inserted into median raphe posteriorly. 
These muscles overlap each other posteriorly, being telescoped into each other like 3 
stacked cups (Figure 1.8). During swallowing, the longitudinal muscles elevate and 
shorten larynx while the constrictors contract in a coordinated way to propel the 
bolus into the esophagus.  
 
Figure 1.8: Muscles of pharynx and cheek (Source: Figure 1030, Chapter XI- 
Splanchnology, Gray’s Anatomy of the Human Body 20th Edition. https://s.yimg.com/ 
lq/i/edu/ref/ga/l/1030.gif) 
 
The buccopharyngeal fascia is a thin coat of areolar tissue covering the pharyngeal 
constrictor muscles and contains the pharyngeal plexus of nerves and veins. It is 
loosely attached to the prevertebral fascia posteriorly and styloid process laterally. 
The oropharynx is supplied via the pharyngeal plexus which is formed by the 
pharyngeal branches of glossopharyngeal & vagus nerve and sympathetic fibres from 
superior cervical ganglion. All muscles of pharynx are supplied by vagus nerve 
except stylopharyngeus which is supplied by glossopharyngeal nerve. Sensory 
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innervation is by glossopharyngeal nerve and internal laryngeal nerve (branch of 
vagus). Blood supply is mainly from ascending pharyngeal artery and venous supply 
drains into internal jugular and anterior facial veins. Lymphatic drainage is to the 
upper deep cervical nodes.  
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1.4   OROPHARYNGEAL CANCERS 
Incidence of oropharygeal cancers in the international scene has shown a gradual 
increase over recent years. Statistics in the United States shows incidence had 
increased 2-3% annually from 1973 till 2001 (Andrews, 2009). However, from 2000 
to 2004, the incidence oropharyngeal malignancy increased annually by 5.22%. 
 
Local epidemiology data shows oropharyngeal cancers are also rampant in Malaysia. 
According to National Cancer Registry Report in 2007 (Omar and Ibrahim, 2008), 
there were a total of 66 cases of oropharyngeal cancer cases consisting of tonsil and 
other sites, in which 42 cases were male and 24 cases were female. Table 1.4 and 
Table 1.5 show gender-specific distribution of oropharyngeal cancer incidence by 
ethnic group and site of cancer in 2007 followed by Figure 1.9 illustrating age-
specific distribution of oropharyngeal cancers by gender in 2007. 
   
Table 1.4: Gender-specific distribution of oropharyngeal cancer incidence by ethnic 
group in 2007  
 
Ethnic group Gender 
Male Female 
Malay  6 6 
Chinese 11 7 
Indian 21 6 
 
 
Table 1.5: Gender-specific distribution of oropharyngeal cancer incidence by site of 
cancer in 2007  
 
Site of cancer Gender 
Male Female 
Tonsil 20 18 
Other oropharyngeal sites 22 6 
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Figure 1.9: Age-specific oropharyngeal cancer incidence by gender in 2007 
 
 
Table 1.6 highlights histopathological subtypes seen in oropharyngeal cancers and 
the risk factors involved which predispose to higher chance of acquiring this cancer. 
  
Table 1.6: Histopathological subtypes and associated risk factors of oropharyngeal 
cancers. (Webster, 2008; Bradley, 2008; Birchall and Pope, 2008) 
 
HPE Subtype 
 
Risk Factors 
 
Benign 
-Squamous papilloma  
-Adenoma 
-Fibroma 
-Hemangioma 
-Leiomyoma 
-Lipoma 
-Lymphangioma 
-Schwanoma 
-Neurofibroma 
 
Malignant 
-Squamous cell (70%) 
-Lymphoma (25%) 
-Salivary gland 
  malignancy (<5%)  
-Smoking 
-Alcohol consumption 
-Dietary deficiencies of    
  vitamin A 
-Chronic irritants 
-Poor dental hygiene 
-Syphilis 
-Marijuana smoking 
-HPV 2, 11, 16 
-HIV 
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1.5   OVERVIEW OF HUMAN PAPILLOMAVIRUS (HPV) 
HPV belongs to Papillomaviridae virus family in which HPV 16 belongs to Alfa-
papillomavirus genus as discussed by Salgado (2011). They are icosahedral, non-
enveloped particles, 55nm in diameter, double-stranded DNA viruses containing 
approximately 7900 base pairs (Torrente, 2007). The genome organization includes 8 
open reading frames and a non-coding region. The six early open reading frames 
(E1-E6) encode proteins involved in DNA replication, transcription and cellular 
transformation; the capsid proteins (L1 & L2) are encoded by late open reading 
frames as shown in Figure 1.10 (Salgado, 2011; Torrente, 2007).  
 
 
 
Figure 1.10: HPV genome; early genes (E1-E6), late genes (L1 & L2), long control 
region (LCR). (Reproduced with permission: Figure 1, Torrente MC, Ojeda JM. 
Exploring the relation between human papilloma virus and larynx cancer. Acta Oto-
Laryngologica 2007; 127: 900-906) 
 
  
Torrente (2007) and Boulet (2007) explain that early genes (E1 & E2) are expressed 
as proteins that bind to DNA and act as transcriptional activators or repressors, thus 
regulating virus transcription and genome replication. The E4 gene is expressed 
relatively late in virus replication and is involved in maturation and release of 
papillomavirus particles. The E6 and E7 gene are viral oncogenes and are responsible 
in producing viral oncogenic proteins. The E6 gene encodes a protein that binds to 
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tumour suppressor protein p53 which induces its degradation. The E7 gene encodes a 
protein that binds to retinoblastoma protein (Rb). The non-coding region or long 
control region (LCR) contain regulatory sequences that respond to steroid receptor 
hormones. 
 
The summary of these genes are shown in Table 1.7. 
Table 1.7: Summary of HPV gene functions (Kajitani et al, 2012) 
Gene 
Product  
Function Activities 
 
E1 
 
Replication of viral genome 
 
 
 
DNA-binding activity, helicase 
activity, ATPase 
E2 1. Transcription of viral genes 
2. Replication and maintenance of 
viral genome 
 
Transactivation/transrepression, 
DNA-binding activity, DNA 
segregation in mitotic cell 
E4 Unknown 
 
 
 
Destruction of keratin network, 
induction of G2
E5 
M arrest of cell 
cycle 
Possibly involved in proliferation 
and/or inhibition of apoptosis 
 
Affection of cellular signaling 
pathway 
E6 1. Reactivation of cellular 
replication mechanisms 
2. Proliferation, immortalization, 
inhibition of apoptosis 
3. Maintenance of viral genome 
 
Interactions with various 
cellular proteins 
E7 1. Reactivation of cellular 
replication mechanisms 
2. Proliferation, genomic 
instability, inhibition of 
apoptosis 
3. Maintenance of viral genome 
 
Interactions with various 
cellular proteins 
L1 Major capsid protein 
 
 
L2 Minor capsid protein 
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These papilloma viruses infect epithelial cells and initial infection involves exposure 
of infectious particles to basal layer. Expression of viral gene product occurs as 
infected basal cell migrates to epithelial surface. 
 
Expression of E6 & E7 in epithelial 
layers drives cells into S-phase, conducive for viral genome replication and cell 
proliferation. In progression towards carcinogenesis, viral genome integrates into 
host genome and this disrupts E2. As a result, E6 & E7 expression is accelerated and 
bind to p53 and retinoblastoma tumour suppressors as mentioned earlier.  
HPV can be classified as low-risk and high risk types based on established cervical 
oncogenicity (Baseman, 2005). Low risk HPV types (eg. type 6 and 11) induce 
benign lesions with minimum risk of progression to malignancy such as in laryngeal 
papilloma (Boulet, 2007; You, 2010; Almadori, 1996; Milian, 1998). On the other 
hand, high risk HPV have higher oncogenic potential with HPV 16 being the most 
prevalent followed by types 18, 31 & 33 (Boulet, 2007; You, 2010). Table 1.8 lists 
down the various types of HPV based on risk classification.  
 
Table 1.8: Classification of HPV types (Baseman, 2005) 
Risk Classification 
 
HPV types 
High risk 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, 82 
 
Probable high risk 26, 53, 66 
 
Low risk 6, 11, 40, 42, 43, 44, 54, 61, 70, 72, 81, CP6108 
 
Undetermined risk 34, 57, 83 
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1.6   LINK BETWEEN ORAL AND OROPHARYNGEAL CANCERS WITH    
        HPV 
Since the 1990’s, a steady rise in incidence in oral cavity cancers especially among 
young males with no history of tobacco or alcohol use (Warnakulasuriya, 2009; 
Chatuwad, 2008) has given rise to a new risk factor, namely human papillomavirus 
(HPV). The role of human papillomavirus (HPV) in oral squamous cell carcinomas 
(OSCC) are evidenced in a few studies (Chatuwad, 2008; Ryerson, 2008; 
Jayaprakash, 2011) and need to be taken in consideration in battling these cancers.  
 
Although overall incidence of oral cavity cancers has decreased in past decades in 
certain countries such as United States of America (USA) and France with annual 
percentage change (APC) of 1.5% and 1.0% respectively (Warnakulasuriya, 2009), 
however HPV-related oral cavity cancers have shown an increase especially among 
younger individuals without typical risk factors such as tobacco or alcohol use as 
observed by Chatuwad (2008). Incidences of HPV-related OSCC in the USA 
increased significantly from 1973 to 2004 with APC of 0.80 (p<0.001) especially 
among younger age group while HPV-unrelated OSCC decreased from 1983 to 2004 
with APC of -1.85 (p<0.001). 
 
Jayaprakash (2011) highlighted the prevalence of HPV at 24.5%, particularly HPV 
16 & 18, among dysplastic and invasive cancers of oral cavity & oropharynx which 
supports the assumption that HPV infection occurs during early phase of these 
cancers. Another study (Hansson, 2005) estimated proportion of HPV infection 
among oral and oropharygeal SCC at 35%.  
 
23 
 
In more recent decades, rising incidence of oropharyngeal cancers also have been 
linked to this virus (Warnakulasuriya, 2009; Timbrell 2011). Andrews (2009) and 
Marur (2010) have shown detection of HPV, especially HPV 16, in tonsils and base 
of tongue cancers up to 85% in young, non-smoking, non-drinking patients. 
Transmission of HPV (although sexual transmission is established in HPV-induced 
cervical cancer) in these cancers point to oro-genital contact and an increase in oral 
sex as mode of HPV transmission to oral mucosa as suggested by Timbrell (2011). 
 
Increased number of sex partners was noted to be a consistent risk factor as studies 
have shown strong association between lifetime number of sex partners and genital 
HPV acquisition both in women and men (Baseman, 2005; Timbrell, 2011, Gabriela, 
2008). 
Clinically, HPV-positive tumours present at an earlier tumour (T) stage but more 
advanced nodal (N) stage and have better treatment outcomes than HPV-negative 
tumours (Chatuwad, 2008; Timbrell, 2011). When treated with radiation, HPV-
positive OSCC have significantly higher survival rate than HPV-negative OSCC at 
all stages (Chatuwad, 2008; Marur 2010; O’Rorke, 2012). Amin Kotb and Petersen 
(2012) discuss that significant differences in HPV-positive and HPV-negative head 
& neck squamous cell carcinoma supports the fact that HPV-positive cancers 
represent a tumour entity of its own that is biologically and clinically different from 
HPV-negative cancers. HPV carcinogenesis is less frequently linked to polyploidy 
and have smaller tumour nuclei than cancers caused by smoking and alcohol. 
 
HPV have also been persistently detected in post treatment HPV-positive patients 
irrespective of tumour site, time interval, type of treatment and presence of 
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recurrence (Morbini, 2013). This suggests that the patients can still be tested post 
treatment whether it is post surgery, post radiotherapy or post chemoradiotherapy.  
 
International Agency for Research on Cancer (IARC), in its monograph released 
2007, have concluded there is sufficient evidence in humans for the carcinogenicity 
of HPV 16 in oral cavity and oropharynx but limited evidence in humans for the 
carcinogenicity of HPV 18 in oral cavity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
